Heron Therapeutics Inc

Research Heron Therapeutics Inc (HRTX) on Bullrun: market cap USD 82.43M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerHRTX
• ExchangeNASDAQ
• CountryUnited States
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 82.43M
• Financial periodFY2025
• RevenueUSD 154.90M
• Revenue growth7.4%
• Net income-USD 20.00M
• Free cash flow-USD 27.91M
• Gross margin73.3%

Valuation Snapshot

latest market cap is USD 82.43M.

About Heron Therapeutics Inc

Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care. The company's product candidates utilize its proprietary Biochronomer, a drug delivery technology, which delivers therapeutic levels of a range of short-acting pharmacological agents over a period from days to weeks with a single administration.

Frequently asked questions

What is Heron Therapeutics Inc's market cap?

Heron Therapeutics Inc's market capitalization is USD 82.43M.

What does Heron Therapeutics Inc do?

Heron Therapeutics, Inc., a commercial-stage biotechnology company, engages in developing and commercializing therapeutic that enhances medical care.